Skip to main content
Caplight Logo









Proteon Pharmaceuticals

Proteon Pharmaceuticals

Private
PolandHealthcare & Life Scienceshttps://proteonpharma.com/

Last Round

Grant

Nov 9, 2022

Total Funding Raised

$33.91M

Company Overview

Proteon Pharmaceuticals is a biotechnology company that develops bacteriophage-based products to reduce the need for antibiotics in livestock farming and aquaculture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

bacteriophage technologyphage therapyanimal feed additivesantibiotic alternativesantimicrobial resistanceAMRagritechpoultry healthaquaculture healthanimal healthlivestock healthfood safetyanimal microbiomephage discovery platformSalmonella controlAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proteon Pharmaceuticals Comparables

Compare Proteon Pharmaceuticals with similar companies based on industry and business-model similarity.

Proteon Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PhageLab
88%
Phagos
85%
NexaBiome
84%

Proteon Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 9, 2022
Series BAug 10, 2021
Series AOct 26, 2017
GrantFeb 6, 2017
GrantSep 1, 2016

Key People

Founding team and executive leadership

Jaroslaw Dastych

Founder And CEO

Founding Team

ACCA Mariana Krulikovska

Deputy Chief Financial Officer

Executive Team

Proteon Pharmaceuticals Investors

Notable investors and investment history

Proteon Pharmaceuticals investors
InvestorRounds
Newtree ImpactSeries B
Calouste Gulbenkian FoundationGrant
Bluebio AllianceGrant
PFR Life ScienceSeries B
Aqua-SparkSeries B, Series A
maze impactGrant
Oceano Azul FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2022

    $45K grant round led by Blue Bio Value.

  • Aug 10, 2021

    $25M round led by Aqua-Spark and Nutreco.

Proteon Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Proteon Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Proteon Pharmaceuticals's valuation, stock price, and market status.

Is Proteon Pharmaceuticals a public or private company?

Proteon Pharmaceuticals is a private company.

What is the current stock price of Proteon Pharmaceuticals?

Proteon Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Proteon Pharmaceuticals worth (valuation)?

Valuation information for Proteon Pharmaceuticals is not publicly available.

Can I buy Proteon Pharmaceuticals stock?

Proteon Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Proteon Pharmaceuticals's last funding round?

Proteon Pharmaceuticals's most recent funding round was Accelerator on November 9, 2022.

Who are the main investors in Proteon Pharmaceuticals?

Key investors in Proteon Pharmaceuticals include PFR Life Science, Aqua-Spark, Blue Bio Value.

Will Proteon Pharmaceuticals IPO soon?

No public IPO plans have been announced for Proteon Pharmaceuticals.

How can I track Proteon Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Proteon Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPoland
Employee Range47
Year Founded2005
Last FundingNov 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?